Developments in Point-of-Care Diagnostic Technology for Cancer Detection
<p dir="ltr">Cancer is the cause of death for one in seven individuals worldwide. It is widely acknowledged that screening and early diagnosis are of vital importance for improving the likelihood of recovery. However, given the costly, time-consuming, and invasive nature of the many...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , |
| منشور في: |
2018
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513513543696384 |
|---|---|
| author | Bryony Hayes (18628777) |
| author2 | Caroline Murphy (3440597) Aoife Crawley (17938769) Richard O’Kennedy (713891) |
| author2_role | author author author |
| author_facet | Bryony Hayes (18628777) Caroline Murphy (3440597) Aoife Crawley (17938769) Richard O’Kennedy (713891) |
| author_role | author |
| dc.creator.none.fl_str_mv | Bryony Hayes (18628777) Caroline Murphy (3440597) Aoife Crawley (17938769) Richard O’Kennedy (713891) |
| dc.date.none.fl_str_mv | 2018-06-02T03:00:00Z |
| dc.identifier.none.fl_str_mv | 10.3390/diagnostics8020039 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Developments_in_Point-of-Care_Diagnostic_Technology_for_Cancer_Detection/25919464 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Oncology and carcinogenesis cancer diagnostics point-of-care glycosylation circulating tumor cells prostate cancer biomarkers exosomes autoantibodies |
| dc.title.none.fl_str_mv | Developments in Point-of-Care Diagnostic Technology for Cancer Detection |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">Cancer is the cause of death for one in seven individuals worldwide. It is widely acknowledged that screening and early diagnosis are of vital importance for improving the likelihood of recovery. However, given the costly, time-consuming, and invasive nature of the many methods currently in use, patients often do not take advantage of the services available to them. Consequently, many researchers are exploring the possibility of developing fast, reliable, and non-invasive diagnostic tools that can be used directly or by local physicians at the point-of-care. Herein, we look at the use of established biomarkers in cancer therapy and investigate emerging biomarkers exhibiting future potential. The incorporation of these biomarkers into point-of-care devices could potentially reduce the strain currently experienced by screening programs in hospitals and healthcare systems. Results derived from point-of-care tests should be accurate, sensitive, and generated rapidly to assist in the selection of the best course of treatment for optimal patient care. Essentially, point-of-care diagnostics should enhance the well-being of patients and lead to a reduction in cancer-related deaths.</p><h2>Other Information</h2><p dir="ltr">Published in: Diagnostics<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/diagnostics8020039" target="_blank">https://dx.doi.org/10.3390/diagnostics8020039</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_db79ca10786b2667178e09f0748eceba |
| identifier_str_mv | 10.3390/diagnostics8020039 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/25919464 |
| publishDate | 2018 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Developments in Point-of-Care Diagnostic Technology for Cancer DetectionBryony Hayes (18628777)Caroline Murphy (3440597)Aoife Crawley (17938769)Richard O’Kennedy (713891)Biomedical and clinical sciencesOncology and carcinogenesiscancerdiagnosticspoint-of-careglycosylationcirculating tumor cellsprostate cancerbiomarkersexosomesautoantibodies<p dir="ltr">Cancer is the cause of death for one in seven individuals worldwide. It is widely acknowledged that screening and early diagnosis are of vital importance for improving the likelihood of recovery. However, given the costly, time-consuming, and invasive nature of the many methods currently in use, patients often do not take advantage of the services available to them. Consequently, many researchers are exploring the possibility of developing fast, reliable, and non-invasive diagnostic tools that can be used directly or by local physicians at the point-of-care. Herein, we look at the use of established biomarkers in cancer therapy and investigate emerging biomarkers exhibiting future potential. The incorporation of these biomarkers into point-of-care devices could potentially reduce the strain currently experienced by screening programs in hospitals and healthcare systems. Results derived from point-of-care tests should be accurate, sensitive, and generated rapidly to assist in the selection of the best course of treatment for optimal patient care. Essentially, point-of-care diagnostics should enhance the well-being of patients and lead to a reduction in cancer-related deaths.</p><h2>Other Information</h2><p dir="ltr">Published in: Diagnostics<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/diagnostics8020039" target="_blank">https://dx.doi.org/10.3390/diagnostics8020039</a></p>2018-06-02T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3390/diagnostics8020039https://figshare.com/articles/journal_contribution/Developments_in_Point-of-Care_Diagnostic_Technology_for_Cancer_Detection/25919464CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/259194642018-06-02T03:00:00Z |
| spellingShingle | Developments in Point-of-Care Diagnostic Technology for Cancer Detection Bryony Hayes (18628777) Biomedical and clinical sciences Oncology and carcinogenesis cancer diagnostics point-of-care glycosylation circulating tumor cells prostate cancer biomarkers exosomes autoantibodies |
| status_str | publishedVersion |
| title | Developments in Point-of-Care Diagnostic Technology for Cancer Detection |
| title_full | Developments in Point-of-Care Diagnostic Technology for Cancer Detection |
| title_fullStr | Developments in Point-of-Care Diagnostic Technology for Cancer Detection |
| title_full_unstemmed | Developments in Point-of-Care Diagnostic Technology for Cancer Detection |
| title_short | Developments in Point-of-Care Diagnostic Technology for Cancer Detection |
| title_sort | Developments in Point-of-Care Diagnostic Technology for Cancer Detection |
| topic | Biomedical and clinical sciences Oncology and carcinogenesis cancer diagnostics point-of-care glycosylation circulating tumor cells prostate cancer biomarkers exosomes autoantibodies |